UTILITY Therapeutics Preparing NDA Submission

Pivmecillinam NDA submission targeted for fourth quarter of 2021LONDON, ENGLAND / ACCESSWIRE / June 15, 2021 / UTILITY therapeutics Ltd., a biotechnology company focused on the development and commercialization of two European-approved antibiotics …